2013 Webcast

Please see below for the keynote lectures, plenary and oral sessions for the three days of the Congress. Click either PC or MAC depending on your device.


Thursday 13 June 2013

Official Opening PC / MAC 
Mauro Schechter, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Keynote Lectures 
Residual Immune Dysregulation in Treated HIV infection PC / MAC 
Michael Lederman, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, USA
Prevention of HIV-1 infection 2013: glimmers of hope PC / MAC
Myron Cohen, University of North Carolina School of Medicine, Chapel Hill, USA
From HIV to global health: economic issues in the region PC / MAC
Sergio Bautista, National Institute of Public Health Mexico City, Mexico

Update on Antiretrovirals, and Treatment Strategies
Treatment optimisation strategies in low-and middle-income countries PC / MAC
Ian Weller, University College London, London, UK
Initiation and sequencing of antiretroviral regimens PC / MAC
Roy Gulick, Weill Medical College of Cornell University, New York, USA
Resistance in Latin America, is anything different? PC / MAC
Luiz Soto-Ramirez, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico
Clinical and virologic outcomes after changing first antiretroviral regimen at 7 sites in the Caribbean, Central, and South America Network (CCASAnet) PC / MAC
Marcelo Wolff, University of Chile School of Medicine, Santiago, Chile
Next-generation drugs inclusion to the South’s HIV/AIDS programs: The Brazilian experience on third-line drugs PC / MAC 
Carla Zaire, CEPN/Université Paris 13, Rio de Janeiro, Brazil
What does all this mean for our region? PC  / MAC 
Discussant: Carlos del Rio, Hubert Department of Global Health, Rollins School of Public Health  of Emory University, and Emory Center for AIDS Research, Atlanta, USA

Friday 14 June 2013

Hepatitis and HIV
Overview of HIV and hepatitis B and C co-infection PC / MAC
Mark Nelson, Chelsea and Westminster Hospital, London, UK
Availability of treatment in the region and prioritisation of treatment PC / MAC 
Discussant: David Kershenobich, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico
Pharmacokinetic data supporting the potential use of sofosbuvir with antiretrovirals in HIV/HCV co-infected patients PC   / MAC  
Brian Kearney, Gilead Sciences, Foster City, USA

Living Longer with HAART and Non-communicable Diseases and HIV
Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don’t PC  / MAC
Caroline Sabin, University College London, London, UK
Renal dysfunction: real and apparent on HAART PC / MAC 
Anton Pozniak, Chelsea and Westminster Hospital, London, UK
HIV, cardiovascular disease, and ageing PC / MAC
Omar Sued, Huésped Foundation, Buenos Aires, Argentina
What does this mean for our region? PC / MAC
Discussant: Nestor Sosa, Gorgas Memorial Institute, Panama City, Panama

Epidemiology and Clinical Issues of HIV-positive Women in the Americas PC / MAC
Patricia Volkow, National Institute of Cancer, Mexico City, Mexico

Treatment as Prevention: the key to an AIDS and HIV-free generation PC / MAC
Julio Montaner, British Columbia Center for Excellence in HIV & AIDS, Vancouver, Canada

Treatment Guidelines
One world, but how many standards of care? PC / MAC
Pedro Cahn, Huésped Foundation, Buenos Aires, Argentina

Saturday 15 June 2013

HIV eradication: virological chances and clinical perspectives: Keynote Lecture PC / MAC
Carlo-Federico Perno, University of Rome ‘Tor Vergata’, Rome, Italy

Endemic infections in patients with HIV PC / MAC
Juan Sierra Madero, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico

HIV and Vulnerable Populations
Alcohol and non-injected drugs PC / MAC
Marcelo Santos Cruz, Institute of Psychiatry, Federal University of Rio de Janiero, Rio de Janeiro, Brazil
Transgender medicine PC / MAC
Anita Radix, Callen-Lorde Clinic, New York, USA
Social determinants of health and HIV: the experience of prisoners and other populations made vulnerable PC / MAC
Carlos Rodriguez-Diaz, University of Puerto Rico, School of Public Health, Aguas Buenas, Puerto Rico
Questions and answers PC / MAC                  

Access and Treatment, Policy Issues
Overview of barriers to diagnosis, treatment and retention in care PC / MAC
Jean Pape, Center for Global Health, Division of Infectious Diseases, Weill Cornell Medical College, Cornell University, New York, USA and Les Centres GHESKIO, Port-au-Prince, Haiti
Missed opportunties and late diagnosis in HIV infected women in Mexico PC / MAC
Alexandra Martin-OnraetNational Institute of Medical Sciences and Nutrition, Mexico City, Mexico
The Chilean experience in the treatment of AIDS PC / MAC
Marcelo Wolff, University of Chile School of Medicine, Santiago, Chile
Questions and answers PC / MAC

Tuberculosis and HIV
An overview of TB and its treatmentand what does this mean for our region? PC / MAC
Beatriz Grinsztejn, Instituto de Pesquisa clinica Evandro Chagas, Rio de Janeiro, Brazil
Tuberculosis and the immune reconstitution inflammatory syndrome (IRIS) PC / MAC
Mike Lederman, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, USA

Update from the 20th Conference on Retroviruses and Opportunistic Infections (CROI): Pathogenesis, Prevention and Treatment
Ricardo Sobhie Diaz, Infectious Diseases Division, Paulista School of Medicine, Federal University of São Paulo and Retrovirology Laboratory São Paulo, Brazil PC / MAC and
Dan Kuritzkes, Harvard Medical School and Chief Division of Infectious Disease, Brigham Women’s Hospital, Boston, USA PC / MAC 

Closing Remarks from the Chairs PC / MAC
Mauro SchechterFederal University of Rio de Janeiro, Rio de Janeiro, Brazil